Amarin Corporation plc (AMRN) Stock Forecast

NASDAQ: AMRNAnalyst ratings, price target and estimates.

AMRN analyst forecast

as of October 17, 2026
Analyst consensus
Sell
1.50 / 5 from 2 analysts
Price target
$12.50
average of analyst targets
Upside to target
+10.4%
from the latest close
Next earnings
November 4, 2026
EPS estimate $-0.28
52-week range
$11.32 – $20.25

AMRN analyst ratings

2 analysts
Strong buy
00%
Buy
00%
Hold
00%
Sell
150%
Strong sell
150%

Number of analysts at each rating.

AMRN price target

Price $11.32Target $12.50
52-week low $11.3252-week high $20.25

The average of analyst 12-month price targets compared with the latest close and the 52-week range.

AMRN earnings per share estimates

Amarin Corporation plc EPS estimates
PeriodAverageLowHighYear agoGrowthAnalysts
Current quarter (Sep '26)−$0.02−$0.02−$0.02−$0.40+95.0%1
Current fiscal year (2026)−$0.07−$0.07−$0.07−$0.09+22.2%1
Next fiscal year (2027)−$0.06−$0.06−$0.06−$0.07+14.3%1

Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.

AMRN revenue estimates

Amarin Corporation plc revenue estimates
PeriodAverageLowHighGrowthAnalysts
Current quarter (Sep '26)$43.7M$41.4M$46.0M−12.0%2
Current fiscal year (2026)$177.4M$171.5M$183.4M−16.9%2
Next fiscal year (2027)$176.8M$164.6M$189.0M−0.3%2

AMRN EPS: reported and forecast

Reported EPSEstimate (average; low–high)

Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.

AMRN revenue: reported and forecast

Reported revenueEstimate (average; low–high)

AMRN EPS estimate revisions

Amarin Corporation plc EPS estimate revisions
Period90 days ago60 days ago30 days ago7 days agoNowChange (90 d)Revisions (30 d)
Current quarter (Sep '26)−$0.01−$0.01$0.00−$0.02−$0.02+300.0%0 up · 1 down
Current fiscal year (2026)−$0.04−$0.04−$0.03−$0.07−$0.07+100.0%0 up · 1 down
Next fiscal year (2027)$0.06$0.06−$0.02−$0.06−$0.06−209.1%0 up · 1 down

How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.

AMRN earnings surprises

Reported EPSEstimate

Reported EPS vs the consensus estimate for the last 12 quarters; AMRN beat in 8 of 12.

What analysts expect from AMRN

2 analysts cover Amarin; their consensus rating is sell (1.50 on a 1–5 scale, where 5 is a strong buy). The average price target is $12.50, 10.4% above the latest close of $11.32. Analysts expect earnings of −$0.07 per share for 2026, +22.2% from a year earlier. For 2027 the average estimate is −$0.06 per share on revenue of $176.8 million. Amarin beat the EPS estimate in 8 of the last 12 quarters.

Related: AMRN income statement, AMRN key metrics, AMRN chart. See the AMRN stock overview for the latest quote and news.

AMRN forecast FAQ

What is Amarin's price target?

The average analyst price target for Amarin is $12.50, 10.4% above the latest close of $11.32.

Is Amarin a buy, hold or sell?

Of 2 analysts covering Amarin, 0 rate it a strong buy, 0 a buy, 0 a hold, 1 a sell and 1 a strong sell, a consensus of sell. Ratings are opinions, not a recommendation from Quotelinks.

What is Amarin's EPS forecast?

Analysts forecast −$0.07 per share for 2026 (range −$0.07 to −$0.07); for 2027 the estimate is −$0.06.

What is Amarin's revenue forecast?

The average revenue estimate for 2026 is $177.4 million, growth of −16.9%; for 2027 it is $176.8 million.

When does Amarin report earnings?

Amarin is expected to report results for the quarter ending September 30, 2026 on November 4, 2026; the EPS estimate is $-0.28.

Does Amarin usually beat earnings estimates?

Amarin reported EPS at or above the analyst estimate in 8 of the last 12 quarters.

Drug Manufacturers - General: forecast